Results 181 to 190 of about 48,370 (295)

Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma. [PDF]

J Gastrointest Oncol, 2023
Wu J, Sun M, Li Z, Shen Y, Wu Y, Zhang H, Xu Z, Gao Q.   +7 more
europepmc   +1 more source

Expression of transforming growth factor- 1 (TGF- 1) and urokinase-type plasminogen activator (u-PA) genes during arterial repair in the pig [PDF]

, 1996
S.J. Wysocki, Minghao Zheng, Ying Fan, M. D. Lamawansa, A. K. House, Paul E. Norman   +5 more
openalex   +1 more source

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors [PDF]

The Journal of cell biology, 1987
Blasi, F., Vassalli, Jean-Dominique, Dano, K.   +2 more
openaire   +3 more sources

Domain structure and interactions of recombinant urokinase-type plasminogen activator.

, 1992
Valery Novokhatny, Leonid Medved, Andrew P. Mazar, Patrick A. Marcotte, Jack Henkin, K.C. Ingham   +5 more
openalex   +1 more source

Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent [PDF]

, 2005
Wendy M. Mars, Minji Jo, Steven L. Gonias   +2 more
openalex   +1 more source

Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis. [PDF]

Medicine (Baltimore), 2023
Rehan ST, Hussain HU, Ali E, Kumar KA, Tabassum S, Hasanain M, Shaikh A, Ali G, Yousaf Z, Asghar MS.   +9 more
europepmc   +1 more source

Urokinase‐type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications [PDF]

, 2013
Morten Persson, Andreas Kjær
openalex   +1 more source

Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: A meta-analysis. [PDF]

Eur J Clin Invest, 2022
Li Y, Ding Y, Zhao Y, Gui Y, Shen Y, Xiang Q.   +5 more
europepmc   +1 more source

Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.

, 1990
Annemarie Ziegler, Jörg Hagmann, Birgit Kiefer, Yoshikuni Nagamine   +3 more
openalex   +1 more source

Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients. [PDF]

J Pers Med, 2023
Lin WC, Wu TJ, Wang CH, Hsieh YJ, Hsu BG.   +4 more
europepmc   +1 more source